StockData
Pluri Inc. logo

Pluri Inc. (PLUR) stock

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.92−0.06 (-6.62%)

Close on Nov 18, 2026Market cap $11.30MP/E –Yield –

Pluri operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Pluri's operating income for the twelve months ending Jun 30, 2026 was -$24.94M. For fiscal 2026 it was -$24.94M. The highest annual figure on record is -$7.44M in fiscal 2010.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$24.94M–
FY2025Jun 30, 2025-$22.18M–
FY2024Jun 30, 2024-$22.16M–
FY2023Jun 30, 2023-$27.25M–
FY2022Jun 30, 2022-$41.59M–
FY2021Jun 30, 2021-$50.62M–
FY2020Jun 30, 2020-$29.48M–
FY2019Jun 30, 2019-$35.53M–
FY2018Jun 30, 2018-$33.73M–
FY2017Jun 30, 2017-$28.02M–
FY2016Jun 30, 2016-$23.32M–
FY2015Jun 30, 2015-$25.27M–
FY2014Jun 30, 2014-$27.85M–
FY2013Jun 30, 2013-$22.22M–
FY2012Jun 30, 2012-$15.03M–
FY2011Jun 30, 2011-$11.11M–
FY2010Jun 30, 2010-$7.44M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$5.55M–
Q3 FY2026CQ1 2026Mar 31, 2026-$6.54M–
Q2 FY2026CQ4 2025Dec 31, 2025-$6.51M–
Q1 FY2026CQ3 2025Sep 30, 2025-$6.35M–
Q4 FY2025CQ2 2025Jun 30, 2025-$6.62M–
Q3 FY2025CQ1 2025Mar 31, 2025-$5.40M–
Q2 FY2025CQ4 2024Dec 31, 2024-$4.96M–
Q1 FY2025CQ3 2024Sep 30, 2024-$5.20M–
Q4 FY2024CQ2 2024Jun 30, 2024-$6.03M–
Q3 FY2024CQ1 2024Mar 31, 2024-$5.53M–
Q2 FY2024CQ4 2023Dec 31, 2023-$5.21M–
Q1 FY2024CQ3 2023Sep 30, 2023-$5.38M–
Q4 FY2023CQ2 2023Jun 30, 2023-$6.54M–
Q3 FY2023CQ1 2023Mar 31, 2023-$7.10M–
Q2 FY2023CQ4 2022Dec 31, 2022-$6.68M–
Q1 FY2023CQ3 2022Sep 30, 2022-$6.92M–
Q4 FY2022CQ2 2022Jun 30, 2022-$8.88M–
Q3 FY2022CQ1 2022Mar 31, 2022-$10.48M–
Q2 FY2022CQ4 2021Dec 31, 2021-$10.80M–
Q1 FY2022CQ3 2021Sep 30, 2021-$11.44M–
Q4 FY2021CQ2 2021Jun 30, 2021-$14.59M–
Q3 FY2021CQ1 2021Mar 31, 2021-$14.23M–
Q2 FY2021CQ4 2020Dec 31, 2020-$13.07M–
Q1 FY2021CQ3 2020Sep 30, 2020-$8.74M–
Q4 FY2020CQ2 2020Jun 30, 2020-$8.51M–
Q3 FY2020CQ1 2020Mar 31, 2020-$7.40M–
Q2 FY2020CQ4 2019Dec 31, 2019-$6.37M–
Q1 FY2020CQ3 2019Sep 30, 2019-$7.20M–
Q4 FY2019CQ2 2019Jun 30, 2019-$7.93M–
Q3 FY2019CQ1 2019Mar 31, 2019-$10.30M–
Q2 FY2019CQ4 2018Dec 31, 2018-$8.33M–
Q1 FY2019CQ3 2018Sep 30, 2018-$8.97M–
Q4 FY2018CQ2 2018Jun 30, 2018-$8.78M–
Q3 FY2018CQ1 2018Mar 31, 2018-$9.05M–
Q2 FY2018CQ4 2017Dec 31, 2017-$8.47M–
Q1 FY2018CQ3 2017Sep 30, 2017-$7.44M–
Q4 FY2017CQ2 2017Jun 30, 2017-$6.59M–
Q3 FY2017CQ1 2017Mar 31, 2017-$8.22M–
Q2 FY2017CQ4 2016Dec 31, 2016-$6.65M–
Q1 FY2017CQ3 2016Sep 30, 2016-$6.56M–

More Pluri figures

See a number that looks wrong?